Fictional example. Northstar Labs, its product, figures, findings and milestones are invented solely to demonstrate report design. They must not be treated as benchmarks or relied upon for a real deal.
Investment committee · regulatory note
Northstar Labs — Series A
Executive question
Can Northstar launch its connected indoor-air monitor in the EU within the current round and nine-month plan?
Scope assessed
Consumer product configuration v3.2, mobile application, radio module, “healthier indoor environment” claims and direct-to-consumer launch in Germany.
Pitch assumption
Management assumes module-level radio evidence is sufficient and budgets €18,000 for all EU market-entry work before launch.
Likely route
Multiple connected-product requirements are likely to apply. Finished-product evidence and cybersecurity obligations need product-specific confirmation.
Route confidence: medium. The hardware configuration is stable, but final claims and the software update model are not frozen.
Budget exposure
Illustrative planning range: €38,000–€72,000, excluding product redesign and VAT.
The upper range is driven by finished-product testing, cybersecurity evidence gaps and corrective work if supplier documentation cannot be relied upon.
Timeline exposure
The nine-month plan remains possible only if claims freeze in month one, supplier evidence is released promptly and no material radio or cybersecurity rework is required.
Critical unknowns
- Whether module evidence covers integration in the finished enclosure and antenna configuration.
- Whether marketing claims imply performance that needs additional substantiation.
- Whether the update and vulnerability-handling process is sufficiently defined.
Financing impact
The current operating plan underfunds the illustrative regulatory range. Reserve capital or a reduced first-launch scope is needed to protect the next financing milestone.
Conditions precedent
- Freeze the assessed product, intended purpose and launch claims.
- Obtain and review the supplier evidence package for the exact radio module version.
- Approve a regulatory budget reserve against the scoped low–high range.
First 90 days
- Day 30: product and claims baseline approved.
- Day 60: finished-product test scope and cybersecurity gap plan confirmed.
- Day 90: evidence owners, budget and critical-path launch plan approved by the board.
How to read the memo
How should an investor read a regulatory investment memo?
A regulatory investment memo should state the decision, confidence, evidence and assumptions before the supporting technical detail. A conditional conclusion is not a weak conclusion. It tells the investment committee exactly what evidence would preserve or change the thesis, how the uncertainty affects runway and who should own the next step.
Limitations
Real assessments depend on the exact product and evidence.
The figures above are invented and are not price guidance. A real report would state its sources, exclusions, confidence and unpriced items. It may also recommend legal counsel, laboratory scoping or specialist classification work before an investor relies on a conclusion.